U.K. Automated Microbiology Market 2021: Supplier Shares and Strategies, Country Segment Forecasts--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

July 2017 | 415 pages | ID: UEA26C04960EN
Venture Planning Group

Abstracts

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500.

VPGMarketResearch.com's new report is an analysis of major business opportunities emerging in the U.K. automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after- the- fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding U.K. microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Market Segmentation Analysis

• Sales and market shares for major suppliers by individual test.
• Volume and sales forecasts for over 100 infectious disease assays by individual test:
• Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
• Review of the market dynamics, trends, structure, size, growth and major suppliers.

Specimen Types

• Urine
• Sterile Fluids: Blood, Serum, CSF
• Throat Swabs, Respiratory Secretions
• Genital Secretions
• Stool
• Abscess/Wound
• Sputum
• Saliva

Applications

• Microbial Identification
• Antibiotic Susceptibility
• Urine Screening
• Blood Cultures

Review of Major Automated Systems

• Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
• The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio- Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen- Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy- Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

• Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
• Global listings of companies developing or marketing microbiology products by individual test.

Competitive Assessments

• Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
• The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux, Bio- Rad, Biotest, CellMark Forensics/LabCorp, Cepheid, Decode Genetics, Diadexus, Diamedix/Erba, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen- Probe, ID Biomedical/GSK, Illumina, Kreatech/Leica, Li- Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho- Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Shimadzu, Siemens, Sierra Molecular, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.

Opportunities and Strategic Recommendations

• Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
• Design criteria for decentralized testing products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contains 415 pages and 72 tables

Contents

1. WORLDWIDE BUSINESS ENVIRONMENT

2. WORLDWIDE MARKET STRUCTURE

3. WORLDWIDE MARKET SIZE AND GROWTH

4. MAJOR INFECTIOUS DISEASE TESTS

  1. AIDS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2. ADENOVIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    d. AdenoAssociated Viruses(AAV)
  3. AEROMONAS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. ANTHRAX/BACILLUS ANTHRACIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. ARBOVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. BABESIOSIS
    a. Background
  7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER BARTONELLA (ROCHALIMAEA)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  8. BLASTOCYSTIS HOMINIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  9. BRUCELLA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  10. CAMPYLOBACTER
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  11. CANDIDA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  12. CHAGAS DISEASE
    a. Background
  13. CHANCROID
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  14. CHLAMYDIA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  15. CLOSTRIDIUM DIFFICILE
    a. Background
    b. Diagnostic Tests
    c. Drugs and Vaccines
  16. CORONAVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  17. COXSACKIEVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  18. CREUTZFELDTJAKOB’S DISEASE
    a. Background
    b. Diagnostic Tests
    c. Vaccines
  19. CRYPTOSPORIDIUM PARVUM
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  20. CYCLOSPORA CAYETANENSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  21. CYTOMEGALOVIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  22. EBOLA VIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  23. E. COLI
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  24. ECHOVIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  25. ENCEPHALITIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  26. ENTEROVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  27. EPSTEINBARR VIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  28. GIARDIA LAMBLIA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  29. GONORRHEA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  30. GRANULOMA INGUINALE
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  31. HANTAVIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  32. HELICOBACTER PYLORI
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  33. HEPATITIS
    a. Background
    b. Hepatitis A
    c. Hepatitis B
    d. Hepatitis C
    e. Vaccines and Drugs
  34. HERPES SIMPLEX VIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  35. HUMAN HERPES VIRUS6 (HHV6)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  36. INFLUENZA VIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  37. LEGIONELLA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  38. LYME DISEASE
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  39. LYMPHOGRANULOMA VENEREUM (LGV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  40. MALARIA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  41. MEASLES (RUBEOLA)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  42. MENINGITIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  43. MICROSPORIDIUM
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  44. MONONUCLEOSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  45. MUMPS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  46. MYCOPLASMA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  47. PAPILLOMAVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  48. PARVOVIRUS B19
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  49. PNEUMONIA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  50. POLYOMAVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  51. PSEUDOMONAS AERUGINOSA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  52. RABIES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  53. RESPIRATORY SYNCYTIAL VIRUS (RSV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  54. RHINOVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  55. ROTAVIRUS (REOVIRUS)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  56. RUBELLA(MEASLES)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  57. SALMONELLOSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  58. SEPTICEMIA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  59. SHIGELLOSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  60. STAPHYLOCOCCUS AUREUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  61. STREPTOCOCCI
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  62. SYPHILIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  63. TOXOPLASMOSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  64. TRICHOMONAS VAGINALIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  65. TUBERCULOSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  66. VIBRIO
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  67. WEST NILE VIRUS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  68. YERSINA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

5. INSTRUMENTATION REVIEW: LEADING ANALYZERS MARKETED BY ABBOTT, BECKMAN COULTER/DANAHER, BIOMERIEUX, ORTHCLINICAL DIAGNOSTICS, ROCHE, SIEMENS, TOSOH, WALLAC AND OTHER SUPPLIERS

6. CURRENT AND EMERGING TECHNOLOGIES

  1. MOLECULAR DIAGNOSTICS
    a. Technology Overview
    b. Amplification Methods
      POLYMERASE CHAIN REACTION
      Temperature Cyclers
      PCR Variations
      IMMUNOPCR
      QCPCR
      DAPPCR
      LIGASE CHAIN REACTION
      BRANCHED DNA
      QBETA REPLICASE
      NUCLEICACID SEQUENCEBASED
      STRAND DISPLACEMENT ACTIVATION
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      OVERVIEW
      ELISA
      DOT IMMUNOBINDING ASSAYS
      CAPILLARY IMMUNOASSAYS
      PARTICLEMEMBRANE CAPTURE IMMUNOASSAYS
      ENZYME AMPLIFICATION
    c. Fluorescent Immunoassays
      FLUORESCENCE POLARIZATION
      TIMERESOLVED PULSE FLUORESCENCE
    d. Luminescence
      CHEMILUMINESCENCE
      BIOLUMINESCENCE
    e. Latex Agglutination
    f. Immunoprecipitation
  4. DIFFERENTIAL LIGHT SCATTERING
  5. IT
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. MRI
  11. GEL MICRODROPLETS
  12. OTHER

7. COMPETITIVE PROFILES

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Table 1: Laboratories Performing Infectious Disease Tests by Country
Table 2: Total Infectious Disease Test Volume Forecast by Country
Table 3: Total Infectious Disease Diagnostics Market Forecast by Country